Therapeutic strategies for congenital myasthenic syndromes
To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...
Hlavní autoři: | Lee, M, Beeson, D, Palace, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Wiley
2018
|
Podobné jednotky
-
The congenital myasthenic syndromes.
Autor: Palace, J, a další
Vydáno: (2008) -
Congenital myasthenic syndromes.
Autor: Beeson, D, a další
Vydáno: (1997) -
Congenital myasthenic syndromes: an update.
Autor: Finlayson, S, a další
Vydáno: (2013) -
Congenital myasthenic syndromes and the neuromuscular junction.
Autor: Cruz, P, a další
Vydáno: (2014) -
The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
Autor: Rodríguez Cruz, P, a další
Vydáno: (2018)